22Mar
HHS Declares Liability Immunity for Certain COVID-19 “Countermeasures”; Response Act Expands Protections for Mask Makers
Earlier this week, we discussed current trends and future implications of COVID-19 on businesses operating in the products arena, noting the most direct impact so far on the pharmaceutical and medical device spaces. Recognizing the potential...
By:
Butler Snow LLP
Related
Thomas H. Lee Partners and Frazier Healthcare Partners have acquired Adare Pharmaceuticals from TPG ...
Read More >
The National Labor Relations Board (the "NLRB" or "Board") issued a Notice of Proposed Rulemaking on...
Read More >
The latest version of Assembly Bill 5, which codifies the California Supreme Court’s Dynamex decisi...
Read More >
Two federal agencies dealing with employment issues, the Federal Trade Commission (FTC) and the Depa...
Read More >
In 2015, Congress passed a law called the Federal Civil Penalties Inflation Adjustment Act Improveme...
Read More >
Employers around the country have a bumpy road to follow as they navigate the ever-changing marijuan...
Read More >